B GROUP, INC.

PrivateCIK: 2043476
Location

DALLAS, TX

πŸ“‹ What this filing means

B GROUP, INC. filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $135.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

20
Positions
$135.95M
Total AUM (reported)
15.08M
Total Shares

Allocation by class

TOTAL AUM$135.95M20 positions
COM$94.83M69.8%
ADR$13.56M10.0%
SPON ADS$9.35M6.9%
COM NEW$7.84M5.8%
COM SHS$5.89M4.3%
*W EXP 05/24/202$4.46M3.3%
COM PAR $.01$22.8K0.0%

Portfolio Concentration

Top 348.9%4–1038.9%11–2512.2%TOP 1087.8%0%100%
Top 3$66.53M48.9%
4–10$52.85M38.9%
11–25$16.57M12.2%

Top 3 weight

48.9%

Top 10 weight

87.8%

Voting Authority Distribution

Total shares with voting rights: 15.08M

Sole

Full voting authority

15.08M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole20
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings20
Rows:

ADMA BIOLOGICS INC

SOLE
COM
Shares2.41M
TypeSH
Market value$35.37M
26.02%
Sole
2.41M
Shared
0.00
None
0.00

ELI LILLY & CO

SOLE
COM
Shares22.50K
TypeSH
Market value$17.17M
12.63%
Sole
22.50K
Shared
0.00
None
0.00

NVIDIA CORPORATION

SOLE
COM
Shares75K
TypeSH
Market value$13.99M
10.29%
Sole
75K
Shared
0.00
None
0.00

ZAI LAB LTD

SOLE
ADR
Shares400K
TypeSH
Market value$13.56M
9.97%
Sole
400K
Shared
0.00
None
0.00

AKERO THERAPEUTICS INC

SOLE
COM
Shares232.45K
TypeSH
Market value$11.04M
8.12%
Sole
232.45K
Shared
0.00
None
0.00

CELLECTIS S A

SOLE
SPON ADS
Shares3.28M
TypeSH
Market value$9.35M
6.88%
Sole
3.28M
Shared
0.00
None
0.00

TAYSHA GENE THERAPIES INC

SOLE
COM SHS
Shares1.80M
TypeSH
Market value$5.89M
4.33%
Sole
1.80M
Shared
0.00
None
0.00

ASSEMBLY BIOSCIENCES INC

SOLE
COM NEW
Shares175.71K
TypeSH
Market value$4.50M
3.31%
Sole
175.71K
Shared
0.00
None
0.00

NRX PHARMACEUTICALS INC

SOLE
*W EXP 05/24/202
Shares3M
TypeSH
Market value$4.46M
3.28%
Sole
3M
Shared
0.00
None
0.00

ULTRAGENYX PHARMACEUTICAL IN

SOLE
COM
Shares135K
TypeSH
Market value$4.06M
2.99%
Sole
135K
Shared
0.00
None
0.00

AURA BIOSCIENCES INC

SOLE
COM
Shares572.58K
TypeSH
Market value$3.54M
2.60%
Sole
572.58K
Shared
0.00
None
0.00

IOVANCE BIOTHERAPEUTICS INC

SOLE
COM
Shares1.50M
TypeSH
Market value$3.25M
2.39%
Sole
1.50M
Shared
0.00
None
0.00

SIGHT SCIENCES INC

SOLE
COM
Shares930K
TypeSH
Market value$3.20M
2.35%
Sole
930K
Shared
0.00
None
0.00

SPYRE THERAPEUTICS INC

SOLE
COM NEW
Shares100K
TypeSH
Market value$1.68M
1.23%
Sole
100K
Shared
0.00
None
0.00

PRAXIS PRECISION MEDICINES I

SOLE
COM NEW
Shares31.50K
TypeSH
Market value$1.67M
1.23%
Sole
31.50K
Shared
0.00
None
0.00

ORUKA THERAPEUTICS INC

SOLE
COM
Shares75K
TypeSH
Market value$1.44M
1.06%
Sole
75K
Shared
0.00
None
0.00

APOGEE THERAPEUTICS INC

SOLE
COM
Shares35K
TypeSH
Market value$1.39M
1.02%
Sole
35K
Shared
0.00
None
0.00

REPLIMUNE GROUP INC

SOLE
COM
Shares50K
TypeSH
Market value$209.5K
0.15%
Sole
50K
Shared
0.00
None
0.00

GAMESQUARE HLDGS INC

SOLE
COM
Shares250K
TypeSH
Market value$169.7K
0.12%
Sole
250K
Shared
0.00
None
0.00

INSMED INC

SOLE
COM PAR $.01
Shares158.00
TypeSH
Market value$22.8K
0.02%
Sole
158.00
Shared
0.00
None
0.00
B GROUP, INC. 13F Holdings β€” 20 Positions | Finecho